MINISTER OF HEALTH EXTENDS APPRECIATION FOR THE ESTABLISHMENT OF THE SAUDI NIH
His Excellency the Minister of Health, Chairman of the Board of Directors of the Saudi National Institute of Health, Mr. Fahad bin Abdulrahman Al-Jalajel
The Saudi National Institute of Health was established to oversee and support transitional research and clinical trials in the field of health and aims to contribute to improving the health, well-being and quality of life of society, fund transitional research and clinical trials in the field of health and ensure the quality and efficiency of its outputs and transform the results of such research into health and economic benefits, including its investment in coordination with the relevant authorities. The Saudi NIH also aims to contribute to the consolidation of the efforts of stakeholders in transitional research and clinical trials.
Managing research grants, and scientific review processes
Tracking and analyzing clinical trial in the Kingdom, in collaboration with the relevant stakeholders
Since the inception of the Saudi National Institute of Health, we aspire to contribute to ensuring the quality and efficiency of competitive and high-quality national health research outputs aimed at improving the health, well-being and quality of life of society. We look forward to participating in and contributing to the consolidation of health research stakeholders' efforts by setting priorities, developing strategies and formulating plans, mechanisms and incentives to transform research into discoveries and knowledge with health and economic benefits.
Prof. Fars Alanazi
Chief Executive Officer
His Excellency the Minister of Health, Chairman of the Board of Directors of the Saudi National Institute of Health, Mr. Fahad bin Abdulrahman Al-Jalajel
CEO of the Saudi National Institute of Health, Professor Faris Al-Anazi, on behalf of the staff of the National Institute of Health and all researchers in the health sector